Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

(Reuters) -Bristol Myers Squibb said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks ...

He will be replaced as CEO by Christopher Boerner, currently head of commercialisation at the group, who will prepare for the top job with an immediate move to the role of chief operating officer.

(Reuters) -Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in ...

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on Monday, and was later confirmed to Reuters by a company spokesperson.